Palisade Bio, Inc. · NASDAQ:PALI
Soleus Capital Master Fund, L.P. reported a 7.50% stake in Palisade Bio, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 13, 2026
Soleus Capital Master Fund, L.P. reported a 7.50% stake in Palisade Bio, Inc., 13,063,687 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).
- Stake
- 7.50%
- Shares
- 13,063,687
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Soleus Capital Master Fund, L.P. | 7.50% | 13,063,687 |
| Soleus Capital, LLC | 7.50% | 13,063,687 |
| Soleus Capital Group, LLC | 7.50% | 13,063,687 |
| Soleus Capital Management, L.P. | 7.50% | 13,063,687 |
| Soleus GP, LLC | 7.50% | 13,063,687 |
| Guy Levy | 7.50% | 13,063,687 |
Source
Related
- Palisade Bio, Inc.
- Soleus Capital Master Fund, L.P.
- Palisade Bio, Inc. shareholders
- Schedule 13G · Soleus Capital Master Fund, L.P. · May 27, 2026
- Form 4 · Capers Julien E. · Oct 21, 2026
- Form 4 · Finley John David · Oct 7, 2026
- Form 4 · Jones Mitchell Lawrence · Oct 7, 2026
- Form 4 · Williams Donald Allen · Oct 5, 2026
- Form 4 · Finley John David · Aug 21, 2026